NASDAQ:IPHA - Nasdaq - US45781K2042 - ADR
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 24.85M | 51.90M | 49.58M | 12.11M | 56.16M | |||
Cost Of Goods | 2.98M | 2.85M | 3.58M | 3.06M | 3.59M | |||
Gross Profit | 21.87M | 49.05M | 46.00M | 9.05M | 52.56M | |||
Operating Expenses | 60.45M | 61.72M | 62.42M | 56.87M | 51.49M | |||
Research and Development | 47.12M | 49.44M | 45.46M | 41.21M | 37.74M | |||
Selling, General, and Administrative Expenses | 17.10M | 16.69M | 20.24M | 23.35M | 17.54M | |||
Operating Income | -38.58M | -12.67M | -16.42M | -47.83M | 1.08M | |||
Interest Income/Expense | 2.46M | 3.45M | 1.09M | 1.26M | -1.36M | |||
Other Income/Expense | 2.08M | 1.65M | -1.63M | 1.08M | -552.00K | |||
Non Recurring Items | N/A | 0.00 | -41.00M | N/A | -43.53M | |||
Income Before Taxes | -34.05M | -7.57M | -57.97M | -45.48M | -829.00K | |||
Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Net Income | -34.05M | -7.57M | -58.10M | -52.81M | -63.98M | |||
EBITDA | -36.00M | -7.58M | 28.98M | -43.23M | 57.88M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.41 | -0.09 | -0.71 | -0.64 | -0.79 | |||
Statistics | ||||||||
Gross Profit Margin | 88.00% | 94.50% | 92.78% | 74.69% | 93.61% | |||
Profit Margin | -137.03% | -14.59% | -117.19% | -436.01% | -113.94% | |||
Operating Profit Margin | -155.27% | -24.41% | -33.13% | -394.86% | 1.92% |
All data in EUR